MakACheungMWChiewHJ, et al.Global trend of survival and damage of systemic lupus erythematosus: meta-analysis and meta-regression. Semin Arthritis Rheum2012; 41: 830–839.
2.
HoussiauFAVasconcelosCD'CruzD, et al.Immunosuppressive therapy in lupus nephritis: the eEuro-Lupus Nephritis Trial. Arthritis Rheum2002; 46: 2121–2131.
3.
CheckleyWWhiteACJrJaganathD, et al.Global burden and diagnostics of cryptosporidium. Lancet Infect Dis2015; 15: 85–94.
4.
HunterPRNicholsG. Epidemiology and clinical features of cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev2002; 15: 145–154.
5.
DoriaAZenMCanovaM, et al.SLE Diagnosis and treatment: when early is early. Autoimmun Rev2010; 10: 55–60.
6.
DanchenkoNSatiaJAAnthonyMS. Epidemiology of systemic lupus erythematosus worldwide. Lupus2006; 15: 308–318.
